A pilot phase I dose finding safety study of the thrombopoietin-receptor agonist, eltrombopag, in patients with myelodysplastic syndrome treated with azacitidine. (2014)

First Author: Svensson T
Attributed to:  Confidence in Concept 2012 - University of Oxford funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1111/ejh.12383

PubMed Identifier: 24853277

Publication URI: http://europepmc.org/abstract/MED/24853277

Type: Journal Article/Review

Volume: 93

Parent Publication: European journal of haematology

Issue: 5

ISSN: 0902-4441